Akums Launches Rabeprazole+Levosulpiride SR Capsules in India

Akums launches rabeprazole+levosulpiride SR capsules in India pioneering relief for GERD patients

Overview

Akums Drugs & Pharmaceuticals Ltd., one of the country’s largest India-CDMO serving the Indian domestic pharmaceutical industry, has announced the launch of Rabeprazole + Levosulpiride SR Capsules. Approved by the Drug Controller General of India (DCGI), this marks the first time such a formulation has been made available in India, promising relief for patients suffering from gastrointestinal tract (GIT) disorders.

GERD 

• GERD, or gastro-oesophageal reflux disease, is a debilitating condition characterised by the reflux of stomach contents into the oesophagus, leading to troublesome symptoms and potential complications. 
• With GERD often dubbed as chronic acid reflux, its prolonged presence not only impacts the quality of life but also poses risks of serious health complications, including stomach and esophageal cancer. 

Rabeprazole Sodium

• Rabeprazole sodium, a potent antisecretory compound, selectively inhibits gastric acid secretion by targeting the H+ and K+ ATPase at the surface of gastric parietal cells. 
• It has demonstrated efficacy in treating gastric and duodenal ulcers, as well as GERD.
• Complementing rabeprazole, levosulpiride, the levo-enantiomer of sulpiride, exhibits significant central antidopaminergic activity and antiemetic effects. 
• Its peripheral anti-dopaminergic action modulates the motor activity of the upper digestive tract, making it valuable in gastro-enterology. 

Words from Akums Drugs & Pharmaceuticals Ltd

• Speaking about the launch, Sanjeev Jain, joint managing director, Akums Drugs & Pharmaceuticals Ltd., commented, “We are thrilled to introduce a novel solution for patients suffering from GERD and related gastrointestinal disorders. GERD diagnosis and treatment rely on symptom management and acid suppression therapies.” 
• “Our rabeprazole + levosulpiride SR capsules offer an effective remedy, easing symptoms, enhancing gastrointestinal function, and boosting patients' overall well-being. Clinical studies have demonstrated that rabeprazole not only alleviates heartburn but also improves other dyspepsia-related symptoms. Levosulpiride offers rapid relief and better healing outcomes with fewer side effects, elevating the overall treatment experience.”
• Jain added, “The first step to curing any ailment is awareness. It's crucial to raise awareness about GERD to mitigate the risk of developing this condition. The introduction of rabeprazole + levosulpiride SR capsules shows Akums' commitment to effective top-notch pharmaceutical solutions that cater to unmet medical needs. We are optimistic that this novel formulation will make a meaningful difference in the lives of patients. I must appreciate the efforts of our R&D team that has helped in bringing this formulation. 

Hard Gelatin Capsule: Content

• Each hard gelatin capsule contains rabeprazole sodium IP 40 mg (as enteric-coated form) and levosulpiride 75 mg (as uncoated sustained-release form). 
• The recommended dosage is one capsule once daily or as directed by a physician.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!